Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05229939 · ClinicalTrials.gov registry record
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients
A clinical trial, sponsored by Paris Translational Research Center for Organ Transplantation.
- Completed
- Registry status
- 11,412
- Enrollment target
NCT05229939: Completed study, sponsored by Paris Translational Research Center for Organ Transplantation.
NCT05229939 is a clinical trial that has completed, run by Paris Translational Research Center for Organ Transplantation. The registered enrollment target is 11,412 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05229939 has completed, sponsored by Paris Translational Research Center for Organ Transplantation.
- COMPLETED
- Registry status
- 11,412 participants
- Enrollment target
Study Summary
Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native kidneys, but their performances in transplant kidney population remains unknown. We aimed at developing a kidney-transplant-specific GFR equation, and comparing its performance to standard GFR equations.
Primary Outcome
Isotopic measurements of GFR
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,412 participants |
| Start Date | 2000-01-01 |
| Est. Completion | 2021-01-01 |
What the finished NCT05229939 record still lists
NCT05229939 is an observational study that tracks outcomes without assigning an intervention. Its 11,412 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05229939 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05229939 about?
NCT05229939 is a clinical study titled "Estimating Glomerular Filtration Rate in Kidney Transplant Recipients". Accurate estimation of the glomerular filtration rate (GFR) is crucial for the management of kidney recipients, since it is the most predictive parameter of allograft failure that drives patient monitoring and decision-making. Standard and recent race-free GFR equations have been developed in native...
What is the current status of trial NCT05229939?
This trial is currently completed. The enrollment target is 11,412 participants. The study started on 2000-01-01. Estimated completion is 2021-01-01.
What interventions are being tested in trial NCT05229939?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05229939?
This trial is sponsored by Paris Translational Research Center for Organ Transplantation, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06677060 · 11,300 participants · Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- NCT07064473 · 11,800 participants · Phase 3
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI